Mahery Amy's most recent trade in Cns Pharmaceuticals Inc was a trade of 17,500 Restricted Stock Units done . Disclosure was reported to the exchange on April 8, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cns Pharmaceuticals Inc | Amy Mahery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 47,420 | - | - | Restricted Stock Units | |
| Cns Pharmaceuticals Inc | Amy Mahery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 29,920 | - | - | Option to purchase common stock | |
| Cns Pharmaceuticals Inc | Mahery Amy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 12,420 | 12,420 | - | - | Option to purchase common stock |